Ambu A/S 最大收入来源是 Urology, Ear-Nose-Throat, and Gastroenterology,在最近的收益报告中收入为 1,826,000,000。就地区而言, United States 是 Ambu A/S 的主要市场,收入为 2,980,000,000。
Ambu A/S 是否盈利?
否,根据最新的财务报表,Ambu A/S 的净亏损为 $0
Ambu A/S 有负债吗?
否,Ambu A/S 的负债为 0
Ambu A/S 的流通股有多少?
Ambu A/S 的总流通股为 0
关键数据
前收盘价
$10.86
开盘价
$10.86
当日区间
-
52周范围
-
交易量
500
平均成交量
140
股息收益率
--
每股收益(TTM)
0.27
市值
--
什么是 Ambu A/S?
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products such as resuscitators, face masks and laryngeal masks. The Patient Monitoring & Diagnostics business area comprises single use electrodes for cardiological and neurological examinations. The target groups for these products are hospitals, clinics, ambulance services and sleep labs. The Emergency Care business area offers ventilation bags, neck collars and manikins for first-aid training. The firm markets its products worldwide. The firm operates King Systems Inc, First Water Heathcote Ltd and Invendo Medical GmbH as subsidiaries.